Quick Answer
Imunon, Inc. reported Net Income of -$14.50 million for fiscal year 2025.
Imunon, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$14.50M | +22.2% |
| 2024 | -$18.62M | +4.6% |
| 2023 | -$19.51M | +45.6% |
| 2022 | -$35.90M | -72.8% |
| 2021 | -$20.77M | +3.3% |
| 2020 | -$21.48M | -27.5% |
| 2019 | -$16.85M | -41.8% |
| 2018 | -$11.88M | +41.8% |
| 2017 | -$20.40M | +7.5% |
| 2016 | -$22.05M | +1.8% |
| 2015 | -$22.46M | +11.9% |
| 2014 | -$25.49M | -209.0% |
| 2013 | -$8.25M | +68.9% |
| 2012 | -$26.57M | -14.4% |
| 2011 | -$23.22M | -23.4% |
| 2010 | -$18.82M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.43M | +29.2% | -25.1% |
| June 30, 2025 | -$2.74M | +42.8% | +33.2% |
| March 31, 2025 | -$4.10M | +16.8% | +15.3% |
| September 30, 2024 | -$4.85M | -39.4% | -1.2% |
| June 30, 2024 | -$4.79M | +13.9% | +2.9% |
| March 31, 2024 | -$4.93M | +11.8% | -41.8% |
| September 30, 2023 | -$3.48M | +43.5% | +37.5% |
| June 30, 2023 | -$5.56M | +8.0% | +0.6% |
- Imunon, Inc. showed an increase of +22.2% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, Imunon, Inc.’s net income has grown by 23.0% (from -$18.82 million to -$14.50 million).
- The most recent figure is from Imunon, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: